The Civilian Climate Corps for Jobs and Justice Act

Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Client expense: $4,803,802 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Reductions to the Department of Defense budget Department of Defense unfunded priorities/requirements lists FY 2024 defense authorizations and appropriations S. 5255Streamline Pentagon Budgeting Act (117th Congress) H.R. 2670/S 2226NDAA

Client expense: $30,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

H.R. 1466 - Safe RESEARCH Act H.R. 1827 - Pausing Enhanced Pandemic Pathogen Research Act of 2023 H.R. 4421 - Preparing for All Hazards and Pathogen Reauthorization Act H.R. 4002 - Relieving Economic Strain to Enhance American Resilience and Competitiveness in Higher Education and Research Act H.R.5933 - DETERRENT Act H.R.5404 - Countering Chinese Espionage Reporting Act H.R.7085 - BIOSECURE Act Potential Legislation on AI S. 289 - Genomics Data Security Act H.R. 2670 - National Defense Authorization Act for FY24 (NDAA) S. 2226 - National Defense Authorization Act for FY24 (NDAA) S. 2333 - Pandemic and All Hazards Preparedness Reauthorization Act S. ____ - CHIPS 2.0 S. 1351 - Safeguarding American Innovation Act (117th Congress) S.3362 - DETERRENT Act S.2714 - CREATE AI Act of 2023 S.3392 - AREA Act S.3558 - A bill to prohibit contracting with certain biotechnology providers, and for other purposes. -- regarding research-related funding and policy issues affecting higher education institutions and their faculty and students.

Client expense: $75,967 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

PCAOB legislation relating to whistleblower, information sharing, disciplinary proceedings, including S. 865: The PCAOB Enforcement Transparency Act of 2023 and S. 811: SEC Whistleblower Reform Act of 2023 Implementation of Holding Foreign Companies Accountable Act, the Accelerated Holding Foreign Companies Accountable Act, and other related China oversight, including the Trusted Foreign Auditing Act of 2023 (H.R. 6769 / S. 3494) and other related draft legislation Establishing New Authorities for Businesses Laundering and Enabling Risks to Security (ENABLERS) Act, passed in the 117th Congress (Contained in H.R. 7900: The National Defense Authorization Act for FY 2023) ESG/Climate Disclosure Proposals Independence of Accounting Standard Setting H.R. 2670; the National Defense Authorization Act for FY 2024, issues related to DoD contractor conflicts of interest S. 1045 and H.R. 2972: Failed Bank Executives Clawback Act (Section 2 (9)(B)), S. 2190: RECOUP Act (Recovering Executive Compensation Obtained from Unaccountable Practices Act of 2023) PCAOB Release No. 2023-003 (NOCLAR) H.R.3541 - Accounting STEM Pursuit Act of 2023 H.R. 2603 - To require the Securities and Exchange Commission to revise certain thresholds related to smaller reporting companies, accelerated filers, and large accelerated filers, and for other purposes Draft legislation on Streamlining Public Company Accounting Oversight Act Draft legislation related to auditing and AI S.3087 - PROOF Act

Client expense: $510,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)

Reductions to the Department of Defense budget Department of Defense unfunded priorities/requirements lists FY 2024 defense authorizations and appropriations S. 5255Streamline Pentagon Budgeting Act (117th Congress) H.R. 2670/S 2226NDAA

Client expense: $30,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

H.R. 1466 - Safe RESEARCH Act H.R. 1827 - Pausing Enhanced Pandemic Pathogen Research Act of 2023 H.R. 4421 - Preparing for All Hazards and Pathogen Reauthorization Act H.R. 4002 - Relieving Economic Strain to Enhance American Resilience and Competitiveness in Higher Education and Research Act H.R.5933 - DETERRENT Act H.R.5404 - Countering Chinese Espionage Reporting Act S. 289 - Genomics Data Security Act H.R. 2670 - National Defense Authorization Act for FY24 (NDAA) S. 2226 - National Defense Authorization Act for FY24 (NDAA) S. 2333 - Pandemic and All Hazards Preparedness Reauthorization Act S. ____ - CHIPS 2.0 S. 1351 - Safeguarding American Innovation Act (117th Congress) S.3362 - DETERRENT Act S.2714 - CREATE AI Act of 2023 -- regarding research-related funding and policy issues affecting higher education institutions and their faculty and students.

Client expense: $74,678 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Client expense: $5,294,628 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Client expense: $5,294,628 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to STEM education, computer science education, and job training in the CHIPS and Science Act of 2022 (Public Law 117-167) and the National Defense Authorization Act for Fiscal Year 2024 (H.R. 2670).

Client expense: $4,340,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), White House Office

Improvement of ESOP related sole source procurement policies that were originally passed in the FY2022 National Defense Authorization Act. Provision for sole source procurement for follow on contracts through Department of Defense for businesses wholly owned through an employee stock ownership plan. Language was included in the House NDAA H.R.2670 and Senate NDAA S.2226.

Client expense: Not reported · Firm income: $20,000

Government targets: Army, Dept of (Other), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Navy, Dept of, SENATE

Improvement of ESOP related sole source procurement policies that were originally passed in the FY2022 National Defense Authorization Act. Provision for sole source procurement for follow on contracts through Department of Defense for businesses wholly owned through an employee stock ownership plan. Language was included in the House NDAA H.R.2670 and Senate NDAA S.2226.

Client expense: Not reported · Firm income: $20,000

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Navy, Dept of, SENATE

Improvement of ESOP related sole source procurement policies that were originally passed in the FY2022 National Defense Authorization Act. Provision for sole source procurement for follow on contracts through Department of Defense for businesses wholly owned through an employee stock ownership plan. Language was included in the House NDAA H.R.2670 and Senate NDAA S.2226.

Client expense: Not reported · Firm income: $20,000

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Navy, Dept of, SENATE

Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Client expense: $3,973,758 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Client expense: $3,973,758 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

House (H.R. 2670) and Senate (S. 2226) FY 2024 National Defense Authorization Act, issues related to missile defense, space launch, Army Test, national security programs, military construction & facilities, and Space Force, Space Development Agency American Rescue Plan Act of 2021 (Public Law 117-2), issues related to contracting House (H.R. 4365) and Senate (S. 2587) FY 2024 Defense Appropriations Act and FY 2024 Homeland Security Appropriations, including issues related to military construction; national security; defense and cybersecurity; DOD environmental/PFAS/resiliency accounts; Ukraine/Poland defense; general defense contracting House (H.R. 5860) Continuing Appropriations Act, 2024 and Other Extensions Act (P.L. 118-15)

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Microelectronics programs and related issues RDT&E and procurement of microelectronics H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024, RDT&E H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024, RDT&E Monitor the following: Semi-Conductors Cloud computing systems Cybersecurity and implementation related issues Implementation of Public Law 117-167, CHIPS and Science Act SBIR/STTR program issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Microelectronics programs and related issues

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES

Microelectronics programs and related issues RDT&E and procurement of microelectronics H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024, RDT&E H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024, RDT&E Monitor the following: Semi-Conductors Cloud computing systems Cybersecurity and implementation related issues Implementation of Public Law 117-167, CHIPS and Science Act SBIR/STTR program issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Microelectronics programs and related issues

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES

Sustainable Aviation Fuel related issues, as follows: Implementation of Public Law 117-169, Inflation Reduction Act S.1962, AAero Act S.1939, FAA Reauthorization Act of 2023 H.R.3935, the Securing Growth and Robust Leadership in American Aviation Act H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024 Monitor the following: H.R.4820/S.2437, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, FY2024 S.1958, Sustainable Aviation Fuels Accuracy Act

Client expense: $60,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 2670/S. 2226, National Defense Authorization Act S. 142, Preserve Access to Affordable Generics and Biosimilars Act S. 150, Affordable Prescriptions for Patients Act of 2023 S. 315, Taxpayer Research and Contributions Knowledge (TRACK) Act of 2023, including provisions related to university tech transfer S. 1264, Strengthening Medicare and Reducing Taxpayer (SMART) Prices Act S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act Potential legislation similar to H.R. 7430, Protecting American Innovation Act (117th Congress) Potential legislation similar to H.R. 5376, Inflation Reduction Act of 2022 Potential legislation similar to H.R. 5429, Save our Stages Extension Act (117th Congress) Potential legislation similar to H.R. 6058, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2020 Potential legislation similar to S. 1416, Affordable Prescriptions for Patients Act of 2019 Potential legislation similar to S. 3700, Affordable Insulin Now Act (117th Congress) Potential legislation making omnibus year-end appropriations Potential legislation regarding the establishment of a SEP royalty court Potential legislation regarding revisions to the tech transfer framework established under the Bayh-Dole Act (P.L. 96-517) Potential legislation seeking to impose pharmaceutical price controls to private sector payers Potential legislation related to artificial intelligence and intellectual property rights Potential legislation related to patent eligibility reform Potential legislation related to changes in Patent Trial and Appeal Board Proceedings Potential legislation related to right to repair issues in intellectual property rights Various issues relating to implementation of Trade Facilitation and Trade Enforcement Act of 2015 (P.L. 114-125); nomination vacancies relating to intellectual property, including for an Intellectual Property Enforcement Coordinator (IPEC); Office of the Intellectual Property Enforcement Coordinator and the National Intellectual Property Rights Coordination Center; the U.S. Patent and Trademark Office; modernization of the U.S. Copyright Office; patent examination practices and patent quality; U.S. Patent and Trademark Office and Food and Drug Administration collaboration efforts; World Trade Organization pending proposal related to COVID-19 and intellectual property rights; State Departments Office of Authentication; IP issues related to internet counterfeiting and piracy; patent linkage and regulatory data protection; the World Trade Organization; pharmaceutical price controls; IP issues related to prescription drug pricing and labeling; promoting inclusive innovation and diversity initiatives in the intellectual property system; proposed rulemaking regarding changes to Patent Trial and Appeal Board Proceedings; implementation of the Inflation Reduction Act of 2022, Drug Price Negotiation Program (P.L. 117-169, subtitle B); implementation of the Bayh-Dole Act (P.L. 96-517); right to repair issues; emerging issues surrounding artificial intelligence, intellectual property, and data protection; confirmation of NIH director; increased utilization of federal criminal penalties resulting from the passage of the Protect Lawful Streaming Act (PSLA) (P.L. 116-260, Div. Q, Title II), for certain types of copyright infringement via illicit streaming of copyrighted works; intellectual property enforcement priorities at the U.S.-Mexico border; licensing negotiations and remedies for standard-essential patents subject to voluntary F/RAND Commitments; draft 2022-2026 USPTO strategic plan; USPTOs IP Attache Program; funding for the Intellectual Property Enforcement Program in FY24 Appropriations Legislation; the "Reasonable Price Clause" in reauthorization draft of the Pandemic and All Hazards Preparedness Act (PAHPA, P.L. 109-417)

Client expense: $13,590,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office

H.R. 1466 - Safe RESEARCH Act H.R. 1827 - Pausing Enhanced Pandemic Pathogen Research Act of 2023 H.R. 4421 - Preparing for All Hazards and Pathogen Reauthorization Act H.R. 4002 - Relieving Economic Strain to Enhance American Resilience and Competitiveness in Higher Education and Research Act S. 289 - Genomics Data Security Act H.R. 2670 - National Defense Authorization Act for FY24 (NDAA) S. 2226 - National Defense Authorization Act for FY24 (NDAA) S. 2333 - Pandemic and All Hazards Preparedness Reauthorization Act S. ____ - CHIPS 2.0 S. 1351 - Safeguarding American Innovation Act (117th Congress) -- regarding research-related funding and policy issues affecting higher education institutions and their faculty and students.

Client expense: $82,292 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.2321, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY2024, NASA R&D; NOAA R&D; NOAA Operations -- National Water Center; EDA issues; NSF issues; NIST issues; NASA EPSCoR; NSF EPSCoR H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024, Defense R&D S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Higher education and training initiatives; Medical research and development; CDC/public health; NIH funding; IDEA program; Organ allocation issues; Appalachian Regional Commission H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024, University research issues Implementation of Public Law 117-328, Consolidated Appropriations Act, FY2023, generally Monitor the following: H.R.4394/S.2443, Energy and Water Development and Related Agencies Appropriations Act, FY2024, Research and development issues; Science related research and EPSCoR; and UTCs Training in High-demand Roles to Improve Veteran Employment Act (THRIVE Act)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- H.R. 3684, Infrastructure Investment and Jobs Act (117th Congress), all provisions generally and specifically regarding the implementation of programs funded or created by this bill. - H.R. 2670, National Defense Authorization Act, specifically regarding labor standards on federal projects, permitting reform, and the use of apprenticeship programs. - H.R. 5860, Continuing Appropriations Act, 2024, specifically regarding the maintenance of funding for federal agencies. - General outreach regarding the application of Davis-Bacon requirements to federal projects. - General outreach regarding the use of Project Labor Agreements on federal projects. - General outreach regarding registered apprenticeship training and programs. - General outreach regarding labor standards for federal procurements. - H.R. 447, National Apprenticeship Act of 2021 (117th Congress), all provisions. - General outreach regarding labor issues at battery manufacturing and semiconductor manufacturing plants. - General outreach regarding compliance with labor standards on projects funded by the U.S. Department of Energy (DOE).

Client expense: $220,000 · Firm income: Not reported

Government targets: Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of

Life cycle management software, as follows: H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024 H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024 Public Law 117-328, Consolidated Appropriations Act, FY2023 Public Law 117-263, James M Inhofe National Defense Authorization Act for Fiscal Year 2023

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Life cycle management software, as follows: H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024 H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024 Public Law 117-328, Consolidated Appropriations Act, FY2023 Public Law 117-263, James M Inhofe National Defense Authorization Act for Fiscal Year 2023

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Hyperspectral Imagery, as follows: H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024 H.R.2670/s.2226, National Defense Authorization Act for Fiscal Year 2024 Public Law 117-328, Consolidated Appropriations Act, FY2023

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Hyperspectral Imagery, as follows: H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024 H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024 Public Law 117-328, Consolidated Appropriations Act, FY2023

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Aerospace Platforms (UAS) issues; and Persistent ISR, as follows: H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024 H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024 Public Law 117-328, Consolidated Appropriations Act, FY2023, Division C-Department of Defense Appropriations Act, Implementation issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Marines

H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024, Aerospace Platforms (UAS) S.2321, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY2024, NASA Unmanned Aircraft System (UAS) H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024, Aerospace Platforms (UAS) Public Law 117-328, Consolidated Appropriations Act, FY2023, Division C-Department of Defense Appropriations Act, Implementation issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024, Chemical, Biological, Radiological, Nuclear, Explosives (CBRNE) H.R.4365/S.2587, Department of Defense Appropriations, FY2024, Chemical, Biological, Radiological, Nuclear, Explosives (CBRNE) opportunities H.R.4367/S.2625, Department of Homeland Security Appropriations Act, FY2024, Non-Intrusive Inspection systems (NII) Public Law 117-328, Consolidated Appropriations Act, FY2023, Non-Intrusive Inspection systems (NII)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Navy 40 Foot Patrol Boat related issues, as follows: H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024 H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024 Implementation of Public Law 117-328, Consolidated Appropriations Act, FY2023

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Navy, Dept of, SENATE

H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024, Navy 40 Foot Patrol Boat related issues H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024, Navy 40 Foot Patrol Boat related issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Navy 40 Foot Patrol Boat related issues Monitor the following: Ukraine Foreign Assistance Shipyard Facilities to support development and life cycle activities H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024, Buy America, Navy ship components

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Navy, Dept of, SENATE

Flood damage reduction project Public Law 117-58, Infrastructure Investment and Jobs Act, Implementation of Water utility issues Monitor H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024, Water infrastructure issues

Client expense: Not reported · Firm income: $30,000

Government targets: Army, Dept of (Other)

Issues related to STEM education, computer science education, and job training in the CHIPS and Science Act of 2022 (Public Law 117-167) and the National Defense Authorization Act for Fiscal Year 2024 (H.R. 2670).

Client expense: $4,420,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), White House Office

H.R. 1466 - Safe RESEARCH Act H.R. 1827 - Pausing Enhanced Pandemic Pathogen Research Act of 2023 H.R. 4421 - Preparing for All Hazards and Pathogen Reauthorization Act H.R. 2670 - National Defense Authorization Act for FY24 (NDAA) S. 289 - Genomics Data Security Act S. 2226 - National Defense Authorization Act for FY24 (NDAA) S. 2333 - Pandemic and All Hazards Preparedness Reauthorization Act S. ____ - CHIPS 2.0 S. 1351 - Safeguarding American Innovation Act (117th Congress) -- regarding research-related funding and policy issues affecting higher education institutions and their faculty and students.

Client expense: $34,849 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

4/18 Senate Banking Committee Nominations Hearing 6/13 Senate Banking Committee Hearing- The Consumer Financial Protection Bureaus Semi-Annual Report to Congress 6/14 House Financial Services Committee Hearing- The Semi-Annual Report of the Bureau of Consumer Financial Protection H.R. 2798- CFPB Transparency and Accountability Reform Act H.R. 1410- Consumer Financial Protection Commission Act H.R. 1382- TABS Act of 2023 H.R. 1313- Transparency in CFPB Cost-Benefit Analysis Act S. 1362- Transparency in CFPB Cost-Benefit Analysis Act H.R. 1411- CFPB-IG Reform Act of 2023 H.R. 1165- Data Privacy Act of 2023 S.1838- Credit Card Competition Act of 2023 H.R.3881 - Credit Card Competition Act of 2023 Issues related to Zelle payment platform and changes to Regulation E House Financial Services Discussion Draft: Stablecoin Legislation Issues related to Biden Administration Student Loan Forgiveness Plan Issues related to changing UDAAP legislation/ Dodd-Frank UDAAP provisions Issues related to banning arbitration agreements H.R.2670- National Defense Authorization Act for Fiscal Year 2024 H.R. 8152 - American Data Privacy and Protection Act (117th Congress) H.R. ____ - Protecting Consumers From Payment Scams Act Issues related to Section 1034 of Dodd-Frank Act Issues related to CFPB Credit Card Late Fees and Late Payments H.R.4277 - Overdraft Protection Act of 2021 Issues related to By Now/Pay Later Financial Products Issues related to SBA Direct 7(a) lending program H.R. 6037, To prohibit the Administrator of the Small Business Administration from directly making loans under the 7(a) loan program, and for other purposes. (117th Congress) S. 3382, To prohibit the Administrator of the Small Business Administration from directly making loans under the 7(a) loan program. (117th Congress) S. 3056, the Prohibiting IRS Financial Surveillance Act (117th Congress) House/Senate Semi-annual Hearing with the Director of the CFPB Issues related to Cyber Security, Data Security & Breach Notification Issues related to Consumer Data Privacy Issues related to the Community Reinvestment Act Issues related to fair lending and fair banking Issues related to CFPB supervisory authority under Section 1024 Issues related to Dodd-Frank including Section 1033 H.R. 4773, the Consumer Financial Protection Commission Act (117th Congress) Legislation related to establishing a commission at the CFPB Issues related to CFPB Consumer Response Portal Issues related to CFPB Taskforce on Consumer Financial Laws CFPB Section 1071 rulemaking Issues related to Underbanked/Unbanked Consumers Issues related to CFPB agency guidance Issues related to bank fees, including overdraft fees and credit card late fees. Issues related to credit card network interchange fees. Issues related to the Federal Reserve Central Digital Bank Currency Issues related to the Federal Reserve Consumer checking accounts Issues related to the CFPBs and Department of Educations actions on student lending Issues related to disclosures for federal student loans Legislation related to student loan refinancing programs Issues related to bankruptcy protections for student loans Issues related to federal student loan reform Issues related to AML-BSA Reform Issues related to Appropriations Financial Services and General Government Appropriations Issues related to the Fair Credit Reporting Act Issues related to financial regulatory coordination Issues related to SBA 7(a) Loan Program and fees Issues related to the Fair Housing Act Issues related to Fintech Issues related to the E-SIGN Act Issues related to the Bank Secrecy Act and Anti-Money Laundering Issues related to the Counter Terrorism & Illicit Finance Act Issues related to Parent Companies of Industrial Banks and Industrial Loan Companies Regulations: Equal Credit Opportunity issues, Regulation B, 12 CFR Part 1002 Home Mortgage Disclosure Act Issues, Regulation C, 12 CFR Part 1003 Fair Debt Collection Practices Issues, Regulation F, 12 CFR Part 1006 Privacy Issues, 12 CFR Parts 40, 216, 332, 1016 Fair Credit Reporting Issues, 12 CFR Parts 41, 171, 334, 1022 Truth in Lending Issues, Regulation Z, 12 CFR Part 1026 Regulations related to the Dodd-Frank Act, Pub. L. No. 111-203 Issues related to the Higher Education Act Issues related to Electronic Fund Transfer Act, regulation E, 15 U.S.C. 1693 Issues related to FDIC Deposit Insurance Issues related to the Paperwork Reduction Act Issues related to the Military Lending Act Community Reinvestment Act Regulations & Q&A issues Issues related to the Servicemembers Civil Relief Act Issues related to Small Business Act Issues related to the Bank Secrecy Act and Anti-Money Laundering rules Issues related to Section 1033 of Dodd-Frank Issues related to Overdraft and non-sufficient funds (NSF) fees Issues related to Fintech oversight Issues related to Buy Now Pay Later Issues related to CFPB Credit Card Safe Harbor fee Issues related to Section 1071 Small Business Data Collection Issues related to UDAAP exam manual changes

Client expense: $810,000 · Firm income: Not reported

Government targets: Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Treasury, Dept of

Improvement of ESOP related sole source procurement policies that were originally passed in the FY2022 National Defense Authorization Act. Provision for sole source procurement for follow on contracts through Department of Defense for businesses wholly owned through an employee stock ownership plan. Language was included in the House NDAA H.R.2670 and Senate NDAA S.2226.

Client expense: Not reported · Firm income: $110,000

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

Improvement of ESOP related sole source procurement policies that were originally passed in the FY2022 National Defense Authorization Act. Provision for sole source procurement for follow on contracts through Department of Defense for businesses wholly owned through an employee stock ownership plan. Language was included in the House NDAA H.R.2670 and Senate NDAA S.2226.

Client expense: Not reported · Firm income: $110,000

Government targets: Army, Dept of (Other), Defense Logistics Agency, Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

Sustainable Aviation Fuel related issues, as follows: Implementation of Public Law 117-169, Inflation Reduction Act S.1962, AAero Act S.1958, Sustainable Aviation Fuels Accuracy Act S.1902, Hydrogen Aviation Strategy Act S.1899, Hydrogen Development Strategy Act S.1939, FAA FAA Reauthorization Act of 2023 H.R. 3935, the Securing Growth and Robust Leadership in American Aviation Act Monitor the following: Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, FY2024 H.R.2670, National Defense Authorization Act for Fiscal Year 2024

Client expense: $60,000 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)

Monitor the following: Microelectronics programs and related issues RDT&E and procurement of microelectronics; Semi-Conductors; Cloud computing systems; Cybersecurity and implementation related issues, as follows: Implementation of Public Law 117-167, CHIPS and Science Act H.R.4365, Department of Defense Appropriations Act, FY2024 H.R.2670, National Defense Authorization Act for Fiscal Year 2024 President's Budget, FY2024 SBIR/STTR program issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Microelectronics programs and related issues

Client expense: Not reported · Firm income: $20,000

Monitor the following: Microelectronics programs and related issues RDT&E and procurement of microelectronics; Semi-Conductors; Cloud computing systems; Cybersecurity and implementation related issues, as follows: Implementation of Public Law 117-167, CHIPS and Science Act H.R.4365, Department of Defense Appropriations Act, FY2024 H.R.2670, National Defense Authorization Act for Fiscal Year 2024 President's Budget, FY2024 SBIR/STTR program issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Microelectronics programs and related issues

Client expense: Not reported · Firm income: $20,000

Hypersonic Radomes and Apertures; and Advanced materials for missile systems, as follows: H.R.4365, Department of Defense Appropriations, FY2024 H.R.2670, National Defense Authorization Act for Fiscal Year 2024 Monitor the following: Implementation of Public Law 117-328, Consolidated Appropriations Act, FY2023, President's Budget, FY2024 Cooperative Programs with Israel regarding Missile Defense Defense Production Act, Title III Navy precision munitions Hypervelocity projectile technology SBIR/STTR program issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Hypersonic Radomes and Apertures; and Advanced materials for missile systems, as follows: H.R.4365, Department of Defense Appropriations, FY2024 H.R.2670, National Defense Authorization Act for Fiscal Year 2024 Implementation of Public Law 117-328, Consolidated Appropriations Act, FY2023, Monitor President's Budget, FY2024

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Night Vision Systems Modernization; Military Communications Systems; Monitor Naval Training Range Modernization; Monitor Medium Caliber Precision Munitions as follows: H.R.4365, Department of Defense Appropriations, FY2024 H.R.2670, National Defense Authorization Act for Fiscal Year 2024 Monitor implementation of Public Law 117-328, Consolidated Appropriations Act, FY2023

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Corporate Acquisition related issues Night Vision Systems Modernization; Military Communications Systems; Monitor Naval Training Range Modernization; Monitor Medium Caliber Precision Munitions as follows: H.R.4365, Department of Defense Appropriations, FY2024 H.R.2670, National Defense Authorization Act for Fiscal Year 2024 Monitor implementation of Public Law 117-328, Consolidated Appropriations Act, FY2023

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Cybersecurity, supply chain, and IoT issues. Monitor: H.R. 2670, and Senate FY24 National Defense Authorization Acts. H.R.4367, the FY24 Homeland Security Appropriations Act, H.R.4365, the FY24 Defense Appropriations Act and implementation of Public Law 117-328, Consolidated Appropriations Act, FY2023.

Client expense: Not reported · Firm income: $30,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE